Enfermedad de Coats tratada con bevacizumab (Avastin？)

case report: we report a case of coats？ disease in a 10-year-old-girl who presented with a profound visual deficit, exudative retinal detachment, vascular telangiectasias and subretinal lipid, who underwent treatment with an intravitreal injection of bevacizumab (avastin？). serial examinations documented an involutional response with a reduction of the subretinal fluid, exudates and macular thickness. discussion: the aetiology of coats？ disease remains uncertain, as does its optimal management. although resolution of a case depends partially on age, and can even occur spontaneously on rare occasions, intravitreal injections of bevacizumab should be considered when planning treatment.